These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18385935)

  • 1. The value of antinuclear antibodies in primary biliary cirrhosis.
    Gao L; Tian X; Liu B; Zhang F
    Clin Exp Med; 2008 Mar; 8(1):9-15. PubMed ID: 18385935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
    Nakamura M; Kondo H; Mori T; Komori A; Matsuyama M; Ito M; Takii Y; Koyabu M; Yokoyama T; Migita K; Daikoku M; Abiru S; Yatsuhashi H; Takezaki E; Masaki N; Sugi K; Honda K; Adachi H; Nishi H; Watanabe Y; Nakamura Y; Shimada M; Komatsu T; Saito A; Saoshiro T; Harada H; Sodeyama T; Hayashi S; Masumoto A; Sando T; Yamamoto T; Sakai H; Kobayashi M; Muro T; Koga M; Shums Z; Norman GL; Ishibashi H
    Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients.
    Sfakianaki O; Koulentaki M; Tzardi M; Tsangaridou E; Theodoropoulos PA; Castanas E; Kouroumalis EA
    World J Gastroenterol; 2010 Oct; 16(39):4938-43. PubMed ID: 20954280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
    Itoh S; Ichida T; Yoshida T; Hayakawa A; Uchida M; Tashiro-Itoh T; Matsuda Y; Ishihara K; Asakura H
    J Gastroenterol Hepatol; 1998 Mar; 13(3):257-65. PubMed ID: 9570238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
    Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.
    Saito H; Takahashi A; Abe K; Okai K; Katsushima F; Monoe K; Kanno Y; Ohira H
    Fukushima J Med Sci; 2012; 58(2):107-16. PubMed ID: 23237866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
    Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
    J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-driven selection of antibodies against SSA, SSB and the centromere 'complex', including a novel antigen, MIS12 complex, in human salivary glands.
    Takeshita M; Suzuki K; Kaneda Y; Yamane H; Ikeura K; Sato H; Kato S; Tsunoda K; Arase H; Takeuchi T
    Ann Rheum Dis; 2020 Jan; 79(1):150-158. PubMed ID: 31611218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.
    Xu J; Zhang H; Wang C; Jiang P; Han C; Dai Y; Qiu F; Gong Y; Jiang Y; Xu P; Zhang M; Zhang L; Shi X; Chen S; Tian Y; Seldin MF; Gershwin ME; Liu X; Li L
    J Immunol Methods; 2022 Feb; 501():113211. PubMed ID: 34971632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis.
    Huang C; Han W; Wang C; Liu Y; Chen Y; Duan Z
    Dis Markers; 2019; 2019():9121207. PubMed ID: 31737133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.
    Muratori P; Muratori L; Ferrari R; Cassani F; Bianchi G; Lenzi M; Rodrigo L; Linares A; Fuentes D; Bianchi FB
    Am J Gastroenterol; 2003 Feb; 98(2):431-7. PubMed ID: 12591064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of autoantibodies coexisting with anti-centromere antibodies in sera of patients with primary biliary cirrhosis].
    Moteki S; Yoshida H; Nishimaki T; Morito T
    Rinsho Byori; 1990 Aug; 38(8):888-94. PubMed ID: 2232249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
    Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
    Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.
    Imura-Kumada S; Hasegawa M; Matsushita T; Hamaguchi Y; Encabo S; Shums Z; Norman GL; Takehara K; Fujimoto M
    Mod Rheumatol; 2012 Nov; 22(6):892-8. PubMed ID: 22327744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review.
    Valour F; Durupt S; Khenifer S; Durieu I
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
    Nakamura M; Shimizu-Yoshida Y; Takii Y; Komori A; Yokoyama T; Ueki T; Daikoku M; Yano K; Matsumoto T; Migita K; Yatsuhashi H; Ito M; Masaki N; Adachi H; Watanabe Y; Nakamura Y; Saoshiro T; Sodeyama T; Koga M; Shimoda S; Ishibashi H
    J Hepatol; 2005 Mar; 42(3):386-92. PubMed ID: 15710222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
    Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
    Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?
    Yang WH; Yu JH; Nakajima A; Neuberg D; Lindor K; Bloch DB
    Clin Gastroenterol Hepatol; 2004 Dec; 2(12):1116-22. PubMed ID: 15625657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.